Threshold-based insulin-pump interruption for reduction of hypoglycemia.

By R. Bergenstal, D. Klonoff, S. Garg, B. Bode, M. Meredith, R. Slover, A. Ahmann, J. Welsh, Scott W. Lee, F. Kaufman. New England Journal of Medicine, 2013

627 citations recorded by the source corpus.

Subfields: Biomedical Engineering, Endocrinology, Diabetes and Metabolism

View Paper: https://www.semanticscholar.org/paper/68f5b6711725246fd2c8ff0abb158c291c4296d9

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Endocrinology, Diabetes and Metabolism

1. G. Bakris
2. J. Hans DeVries
3. C. A. V. van Beers
4. Rowan Killip
5. M. Vi

Citations in the corpus

• 6. Glycemic Targets: Standards of Medical Care in Diabetes-2022. (2021, methodology): “CGM with automated low glucose suspend and hybrid closed-loop systems have been shown to be effective in reducing hypoglycemia in type 1 diabetes (97).”
• Analysis (2015, background): “However, an effect on severe hypoglycemia has never been established in an randomized controlled trial evaluating the effect of conventional RT-CGM (without threshold suspension) on glycemic control.(7,8,24) Only 1 observational study showed a reduction in severe hypoglycemia.”